Hims & Hers Health (HIMS) EPS (Basic) Growth (3y) (2022 - 2026)
Hims & Hers Health (HIMS) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.44 Bn | 30.77 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.16 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Hims & Hers Health | 7.76 Bn | 6.92 Bn | 480.80 Mn | -121.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -121.34% |
| Mar 31, 2026 | -102.47% |
| Dec 31, 2025 | 54.91% |
| Sep 30, 2025 | 40.26% |
| Jun 30, 2025 | 58.25% |
| Mar 31, 2025 | 68.45% |
| Dec 31, 2024 | 39.63% |
| Sep 30, 2024 | 85.46% |
| Jun 30, 2024 | 48.87% |
| Mar 31, 2024 | 29.17% |
| Dec 31, 2023 | 26.47% |
| Sep 30, 2023 | 50.21% |
| Jun 30, 2023 | 11.02% |
| Mar 31, 2023 | 45.47% |
| Dec 31, 2022 | -53.49% |
| Sep 30, 2022 | -85.71% |
| Jun 30, 2022 | -208.06% |